Nyxoah SA (NYXH) vs Pro-Dex, Inc. (PDEX)

Nyxoah SA and Pro-Dex, Inc. are both Medical Instruments & Supplies companies. Pro-Dex, Inc. is the larger, with a market value of $194.1M against $121.2M — 1.6× the size. Nyxoah SA has negative trailing earnings, so its P/E is not meaningful; Pro-Dex, Inc. trades at 13.8×. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against 16.5%. Pro-Dex, Inc. has the higher net margin (17.6% vs −446.4%) and the higher return on invested capital (15.8% vs −117.8%). Across the 19 metrics below, Pro-Dex, Inc. leads on 13 and Nyxoah SA on 6.

Valuation

Metric NYXH PDEX Medical Instruments & Supplies median
P/E n/m 13.77 33.75
P/S 2.52 2.42 2.52
P/B 0.65 3.95 2.48
Price to free cash flow n/m 27.94 25.19
EV/EBITDA n/m 13.33 14.62
EV/Sales 0.75 2.47 2.88
Earnings yield (227.03%) 7.26% (2.67%)
Free cash flow yield (136.70%) 3.58% 0.09%

Profitability

Metric NYXH PDEX Medical Instruments & Supplies median
Gross margin 60.16% 31.38% 54.29%
Operating margin (391.25%) 16.75% 1.07%
Net margin (446.39%) 17.62% (1.61%)
Free cash flow margin (344.99%) 8.72% 1.08%
Return on equity (124.41%) 32.43% (1.32%)
Return on assets (68.23%) 20.14% 0.00%
Return on invested capital (117.82%) 15.75% 0.00%

Growth

Metric NYXH PDEX Medical Instruments & Supplies median
Revenue growth (TTM) 366.24% 16.45% 8.85%
EPS growth (last fiscal year) (36.22%) 54.31% 8.65%
Revenue growth, 5-year CAGR 170.14% 15.32% 9.17%
Net income growth, 5-year CAGR 0.00% 17.23% 0.00%

Health

Metric NYXH PDEX Medical Instruments & Supplies median
Debt to equity 0.72 0.28 0.10
Current ratio 2.38 4.10 2.48
Net debt to EBITDA 0.08 0.27 0.89

Dividend

Metric NYXH PDEX Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric NYXH PDEX Medical Instruments & Supplies median
Market cap 121.19m 194.06m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack